World Environment Day: UN Secretary-General Reckons with ‘A Moment of Truth’ on Climate Action

The Secretary-General, António Guterres, recently visited Antarctica to see the deadly impact of the climate crisis. Credit: UN Photo/Mark Garten

The Secretary-General, António Guterres, recently visited Antarctica to see the deadly impact of the climate crisis. Credit: UN Photo/Mark Garten

By Naureen Hossain
NEW YORK, Jun 5 2024 – Coming at a time of record-breaking global temperatures over the last twelve months, the UN chief calls on world leaders, including the G20 and G7 members, to commit to their climate action goals as laid out in the Paris Agreement. Experts across multiple industries are also encouraged to do their part to mitigate the impact of the climate crisis.

Today (June 5, 2024) is World Environment Day, which UN Secretary-General António Guterres marked with a special address delivered at the American Museum of Natural History. He warned that global efforts to address the climate crisis need to be strengthened, which would depend on the decisions that world leaders will take in the coming months and years.  In the lead-up to major global conferences such as the G20 and G7 summits, the United Nations General Assembly in September and COP29 this November, this time is considered critical for countries to reassess and reaffirm their nationally determined contributions and their climate action plans.

“The need for action is unprecedented but so is the opportunity—not just to deliver on climate, but on economic prosperity and sustainable development,” said Guterres. “Climate action cannot be captive to geo-political divisions.”

The Secretary-General’s special address also coincided with the release of a new report and findings from the World Meteorological Organization’s (WMO) Global Annual to Decade Climate Update 2024 report. In addition to revealing the 80 percent likelihood of the global annual average temperature exceeding the 1.5 degree limit, the report also notes that the global annual average temperature may exceed the 1.5-degree Celsius limit at least once within the next five years, between 2024 and 2028. There is a high likelihood that one of these years will set a new record temperature high, which could beat 2023, the current hottest year on record.

“WMO is sounding the alarm that we will be exceeding the 1.5°C level on a temporary basis with increasing frequency. We have already temporarily surpassed this level for individual months—and indeed, as averaged over the most recent 12-month period. However, it is important to stress that temporary breaches do not mean that the 1.5 °C goal is permanently lost because this refers to long-term warming over decades,” said WMO Deputy Secretary-General Ko Barrett.

Guterres also drew from data findings from the EU-funded Copernicus Climate Change Service, which found that the highest global average temperature over the last twelve-month period (June 2023–May 2024) was the highest on record, at 1.63 degrees Celsius above the pre-industrial era.

During the speech, Guterres made several key recommendations for world governments and other stakeholders, namely to slash carbon emissions, boost climate financing, and protect people and places from the extremes of climate change. He called on the G20 countries, who account for up to eighty percent of global carbon emissions, to bolster their climate action plans that would include majorly reducing global emissions. They were also called on to show what he referred to as climate solidarity by providing technical and financial support to developing countries’ efforts to meet their goals. G20 economies would not only have the means to take these measures, but they should also be able to set the standard for other countries.

Guterres also called for G20 countries to commit to reducing or ending their use of coal, oil, and gas fuels to reduce supply and demand by sixty percent by 2035. For all other countries, including developing economies, their climate action plans should also “double as investment plans,”  which will spur sustainable development and make use of renewable energy sources to meet the “soaring energy demand.”

Protecting people and places is also of key importance in Guterres’ address, as he recommended ramping up protections from climate chaos, particularly for the most vulnerable communities. Recently, this has manifested through extreme weather conditions such as heatwaves in countries across South and Southeast Asia and heavy storms in Latin America, such as Brazil. All countries will be expected to set out their climate adaptation plans, including accounting for adaptation finance, which goes towards actions to reduce the risks communities face in times of climate hazards. Guterres reiterated that developed countries should honor their commitment to double adaptation financing up to 40 billion USD a year by 2025. He also noted that the gap in adaptation finance must be addressed in COP29 this year.

Guterres took aim at the fossil fuel industry in his speech, referring to it as the “Godfather of climate chaos.” He noted that the industry takes in profits and benefits from taxpayer-subsidies that amount to trillions of dollars and have stood in the way of progress with “relentless zeal” over the years. He noted that the industry has spent far more time and money—billions, even—sowing doubt about alternate energy sources and investing as little as 2.5 percent of their capital in clean energy.

“Doubling down on fossil fuels in the 21st century, is like doubling down on horseshoes and carriage wheels in the 19th (century),” he said.

He went further to urge others to stop extending their support to the fossil fuel industry, calling on financial institutions to stop bankrolling fossil fuel companies, urging advertising and public relations companies to stop working with them to spread their influence, and even calling for countries to ban advertisements for fossil fuels.

Among these harrowing concerns and the stark facts of the immediate impact of climate change, there is still some hope. It has been emphasized that countries already possess the resources to meet the challenges brought on by climate change.

“We are living in unprecedented times, but we also have unprecedented skill in monitoring the climate and this can help inform our actions,” said Carlo Buontempo, Director of Copernicus Climate Change Service. “This string of hottest months will be remembered as comparatively cold but if we manage to stabilize the concentrations of greenhouse gases in the atmosphere in the very near future, we might be able to return to these “cold” temperatures by the end of the century.”

In his speech, Guterres commended those in civil society, the business sector, and activists, along with cities and regions that have advocated for or implemented measures towards environmental consciousness. “You are on the right side of history. You speak for the majority,” he said.

Guterres also noted that the United Nations would be “all in” in finding solutions and encouraging cooperation between stakeholders. This level of cooperation would only yield concrete results with full involvement and commitment to undo the damage caused by man-made climate change. “Now is the time to mobilize. Now is the time to act. Now is the time to deliver. This is our moment of truth.”

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Fortrea schließt Veräußerung der Geschäftsbereiche Endpoint Clinical und Patient Access an Arsenal Capital Partners ab

DURHAM, North Carolina, June 05, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), ein weltweit führendes Auftragsforschungsinstitut (Contract Research Organization, „CRO“), hat heute bekanntgegeben, dass es die Veräußerung von Vermögenswerten seines Segments Enabling Services, d. h. seiner Geschäftsbereiche Endpoint Clinical („Endpoint“) und Fortrea Patient Access („FPA“), an Arsenal Capital Partners („Arsenal“), ein führendes Private–Equity–Unternehmen, das sich auf den Aufbau marktführender, technologieorientierter Wachstumsunternehmen im Gesundheitswesen und in der Industrie spezialisiert hat, abgeschlossen hat.

Endpoint und FPA bieten erstklassige Lösungen für Randomisierung und Trial Supply Management (RTSM) bzw. Patientenzugang. Beide stellen strategisch differenzierte Einstiegspunkte in die Wertschöpfungskette der pharmazeutischen Dienstleistungen dar, in denen Arsenal über bedeutende fachliche, wissenschaftliche und technische Kenntnisse verfügt.

Arsenal hat Sam Osman, ehemaliger President des Segments Enabling Services von Fortrea, zum Chief Executive Officer der neuen Einheiten ernannt, und Raymond („Ray“) H. Hill, ein operativer Partner innerhalb des Healthcare–Teams von Arsenal, wird als Vorsitzender des Verwaltungsrats fungieren.

„Endpoint und FPA sind hervorragend positioniert, um Patienten bei der Durchführung klinischer Studien und beim Zugang zu neuen Therapeutika nach der Zulassung zu unterstützen“, so Sam Osman, Chief Executive Officer von Endpoint und FPA. „Mit Arsenal als Partner bin ich zuversichtlich, dass sowohl unsere Unternehmen als auch unsere Teams von den beschleunigten Wachstumschancen sowie den Investitionen und dem Fokus der Geschäftsführung profitieren werden, was zu verbesserten Fähigkeiten und Lösungen für die Kunden führt.“

„Der erfolgreiche Abschluss dieser Transaktion ist ein Beweis für die Qualität der beteiligten Teams, die einen reibungslosen Übergang für Kollegen, Kunden und die von uns betreuten Patienten geplant haben“, so Tom Pike, Chairman und CEO von Fortrea. „Diese Transaktion ermöglicht es beiden Organisationen, ihre Führung und Ressourcen auf die Bereitstellung optimaler Lösungen für unsere Kunden zu konzentrieren. Wie bereits bekanntgegeben, wird der Nettoerlös aus dieser Veräußerung dazu verwendet, einen Teil der Gesamtverschuldung von Fortrea zu reduzieren. Als reines klinisches Auftragsforschungsinstitut bleibt Fortrea unserer Mission verpflichtet, Lösungen zu liefern, die lebensverändernde Behandlungen schneller zu den Patienten bringen.“

Ray Hill, ein operativer Partner von Arsenal und Vorstandsvorsitzender von Endpoint und FPA, dazu: „Ich freue mich unglaublich, Teil des nächsten Kapitels von Endpoint und FPA zu sein. Darüber hinaus freue ich mich auf die Zusammenarbeit mit dem Managementteam beim Aufbau eines strategisch wichtigen Unternehmens, das datengesteuerte Lösungen für Patienten anbietet.“

Endpoint Clinical

Endpoint ist im wachstumsstarken eClinical–Markt als führender Anbieter von Randomisierungs– und Trial Supply Management (RTSM)–Lösungen für biopharmazeutische und CRO–Kunden tätig und verfügt über Fachwissen bei der Betreuung komplexer klinischer Studien im Spätstadium. Seit mehr als 15 Jahren kann Endpoint auf eine erfolgreiche Erfolgsbilanz bei der effektiven Unterstützung von mehr als 1.750 klinischen Studien mit 875.000 Patienten in 90 Ländern verweisen, hat zudem einen erstklassigen Kundenstamm aufgebaut und langjährige strategische Beziehungen gepflegt.

Fortrea Patient Access

Fortrea Patient Access ist ein führendes Unternehmen auf dem Markt für HUB–Dienstleistungen und Patientenzugang und bietet der biopharmazeutischen Industrie seit mehr als 30 Jahren umfassende Lösungen für Patientenunterstützung, Produktzugang, Erschwinglichkeit und Adhärenz. Durch die kürzlich erweiterte nicht–kommerzielle Spezialapotheke FortreaRx™, die einen verbesserten Vertrieb von Kühlketten– und Ambient–Free–Goods–Produkten ermöglicht, ist Fortrea Patient Access bestrebt, die Ergebnisse für Patienten zu verbessern und die Zugänglichkeit zur Gesundheitsversorgung durch seine umfangreiche Erfahrung zu erhöhen, während es derzeit mehr als 2,5 Millionen Patienten und über 100 einzigartige Marken für mehr als 25 Krankheitsindikationen unterstützt.

Über Arsenal Capital Partners

Arsenal Capital Partners ist eine führende Private–Equity–Firma, die sich auf den Aufbau marktführender Wachstums– und Gesundheitsunternehmen spezialisiert hat. Seit seiner Gründung im Jahr 2000 hat Arsenal institutionelle Beteiligungsfonds in Höhe von insgesamt über 10 Milliarden US–Dollar eingeworben, mehr als 300 Plattform– und Add–on–Akquisitionen abgeschlossen und mehr als 35 Realisierungen erzielt. Die Firma arbeitet mit Managementteams zusammen, um strategisch wichtige Unternehmen mit führenden Marktpositionen, hohem Wachstum und hoher Wertschöpfung aufzubauen. Weitere Informationen erhalten Sie unter www.arsenalcapital.com.

Über Fortrea

Fortrea (Nasdaq: FTRE) ist ein weltweit führender Anbieter von Lösungen für die klinische Entwicklung in der Biowissenschaftsbranche. Wir arbeiten mit aufstrebenden und großen biopharmazeutischen, biotechnologischen, medizintechnischen und diagnostischen Unternehmen zusammen, um Innovationen im Gesundheitswesen voranzutreiben, die das Angebot lebensverändernder Therapien für Patienten beschleunigen. Fortrea bietet Management von klinischen Studien der Phasen I–IV, klinische Pharmakologie und Beratungsdienste an. Die Lösungen von Fortrea basieren auf drei Jahrzehnten Erfahrung in mehr als 20 Therapiegebieten, einer Leidenschaft für wissenschaftliche Strenge, außergewöhnlichen Erkenntnissen und einem starken Netzwerk von Prüfzentren. Unser talentiertes und vielseitiges Team in über 90 Ländern ist so skaliert, dass wir unseren Kunden weltweit gezielte und flexible Lösungen anbieten können. Erfahren Sie mehr darüber, wie Fortrea zu einer transformativen Kraft von der Pipeline bis zum Patienten wird, unter Fortrea.com und folgen Sie uns auf LinkedIn und X (früher Twitter).

Warnhinweis zu zukunftsgerichteten Aussagen

Diese Pressemitteilung enthält „zukunftsgerichtete Aussagen“ im Sinne der US–Bundeswertpapiergesetze, einschließlich Abschnitt 27A des Securities Act und Abschnitt 21E des Exchange Act. Zukunftsgerichtete Aussagen beziehen sich naturgemäß auf Angelegenheiten, die in unterschiedlichem Maße ungewiss sind, einschließlich des Zeitpunkts der Verwendung der Nettoerlöse zur Rückzahlung eines Teils der ausstehenden Schulden des Unternehmens. In diesem Zusammenhang beziehen sich zukunftsgerichtete Aussagen häufig auf die erwartete künftige Geschäfts– und Finanzentwicklung und die Finanzlage. Sie enthalten oft Begriffe wie „Prognose“, „erwarten“, „annehmen“, „vorhersehen“, „beabsichtigen“, „planen“, „voraussagen“, „glauben“, „anstreben“, „sehen“, „werden“, „würden“, „abzielen“ sowie ähnliche Ausdrücke und Variationen oder Verneinungen dieser Begriffe, die dazu dienen, zukunftsgerichtete Aussagen zu identifizieren, obwohl nicht alle zukunftsgerichteten Aussagen diese identifizierenden Wörter enthalten. Die tatsächlichen Ergebnisse können aufgrund einer Reihe von Faktoren erheblich von diesen zukunftsgerichteten Aussagen abweichen, einschließlich, aber nicht beschränkt auf Faktoren, die von Zeit zu Zeit in Dokumenten beschrieben werden, die das Unternehmen bei der SEC einreicht. Eine weitere Erörterung der Risiken im Zusammenhang mit der Geschäftstätigkeit des Unternehmens findet sich im Abschnitt „Risikofaktoren“ des Jahresberichts des Unternehmens auf Formblatt 10–K, der bei der Securities and Exchange Commission (SEC) eingereicht wurde, wobei diese Risikofaktoren von Zeit zu Zeit in den nachfolgenden periodischen und anderen Einreichungen des Unternehmens bei der SEC geändert oder aktualisiert werden können, die auf der Website der SEC unter www.sec.gov abrufbar sind. Diese Faktoren erheben keinen Anspruch auf Vollständigkeit und sollten in Verbindung mit den anderen Warnhinweisen gelesen werden, die in den bei der SEC eingereichten Unterlagen des Unternehmens enthalten oder durch Verweis einbezogen sind. Alle zukunftsgerichteten Aussagen beziehen sich nur auf das Datum dieser Pressemitteilung, und das Unternehmen übernimmt keine Verpflichtung, zukunftsgerichtete Aussagen zu aktualisieren oder zu überarbeiten, um zukünftige Ereignisse oder Entwicklungen zu berücksichtigen, es sei denn, dies ist gesetzlich vorgeschrieben.

Kontakt zu Fortrea:
Hima Inguva (Investoren) – 877–495–0816, hima.inguva@fortrea.com
Sue Zaranek (Medien) – 919–943–5422, media@fortrea.com
Kate Dillon (Medien) – 646–818–9115, kdillon@prosek.com

Kontakt zu Arsenal:

Ellen Pavlovsky – epavlovsky@arsenalcapital.com


GLOBENEWSWIRE (Distribution ID 9148950)

Fortrea cède ses activités Endpoint Clinical et Patient Access à Arsenal Capital Partners

DURHAM, Caroline du Nord, 05 juin 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a annoncé aujourd’hui avoir finalisé la cession des actifs liés à son segment Enabling Services, à savoir ses activités Endpoint Clinical (ci–après « Endpoint ») et Fortrea Patient Access (« FPA »), à Arsenal Capital Partners (« Arsenal »), une société de capital–investissement de premier plan spécialisée dans la création d’entreprises de soins de santé et industrielles leaders sur le marché et à fort profil technologique.

Endpoint et FPA fournissent respectivement des solutions de randomisation et de gestion de l’approvisionnement des essais (« RTSM ») et d’accès aux soins pour les patients de premier plan. Ils représentent tous deux des points d’entrée stratégiquement différenciés dans la chaîne de valeur des services pharmaceutiques, où Arsenal dispose d’une connaissance approfondie des domaines, des sciences et des techniques.

Arsenal a nommé Sam Osman, ancien président du segment Enabling Services de Fortrea, au poste de directeur général des nouvelles entités, et Raymond (« Ray ») H. Hill, partenaire opérationnel au sein de l’équipe de santé d’Arsenal, au poste de président–directeur général du conseil d’administration.

« Endpoint et FPA sont très bien placés pour soutenir le parcours des patients tout au long des essais cliniques et pour leur permettre d’accéder à de nouveaux traitements après leur approbation », a déclaré Sam Osman, président–directeur général d’Endpoint et de FPA. « Avec Arsenal comme partenaire, je suis convaincu que nos deux sociétés et nos équipes bénéficieront d’opportunités de croissance accélérée ainsi que d’investissements et d’une attention particulière de la part des dirigeants, ce qui se traduira par des capacités et des solutions améliorées pour les clients. »

« Le succès de cette transaction témoigne de la qualité des équipes impliquées, qui ont planifié une transition en douceur pour les collègues, les clients et les patients que nous servons », a déclaré Tom Pike, président–directeur général de Fortrea. « Cette transaction permet aux deux organisations de concentrer leur leadership et leurs ressources sur la fourniture de solutions optimales à nos clients. Comme indiqué précédemment, le produit net de cette cession sera utilisé pour réduire une partie de la structure globale de la dette de Fortrea. En tant qu’ORC clinique, Fortrea reste fidèle à sa mission qui consiste à fournir des solutions permettant d’apporter plus rapidement aux patients des traitements qui changent leur vie. »

Ray Hill, partenaire opérationnel d’Arsenal et président du conseil d’administration d’Endpoint et de FPA, a confié : « Je suis incroyablement enthousiaste à l’idée de participer au prochain chapitre d’Endpoint et de FPA. Je me réjouis de travailler avec l’équipe de direction à la construction d’une société stratégiquement importante qui fournit des solutions basées sur des données pour les patients. »

Endpoint Clinical

Endpoint Clinical opère sur le marché à forte croissance de l’« eClinique » en tant que fournisseur de premier plan de solutions de randomisation et de gestion de l’approvisionnement des essais (« RTSM ») pour les clients biopharmaceutiques et les ORC, avec une expertise dans les essais cliniques complexes et en phase avancée de développement. Depuis plus de 15 ans, Endpoint a réussi à soutenir efficacement plus de 1 750 essais cliniques impliquant 875 000 patients dans 90 pays, à cultiver une clientèle de premier ordre et à entretenir des relations stratégiques de longue date.

Fortrea Patient Access

Fortrea Patient Access est un leader du marché des services HUB et de l’accès aux patients. Depuis plus de 30 ans, il propose à l’industrie biopharmaceutique des solutions complètes en matière de soutien aux patients, d’accès aux produits, d’accessibilité financière et d’observance. En outre, grâce à l’expansion récente de sa pharmacie spécialisée non commerciale, FortreaRx™, destinée à soutenir une distribution accrue des produits de la chaîne du froid et des produits gratuits à température ambiante, Fortrea Patient Access s’est engagée à améliorer les résultats pour les patients ainsi que l’accessibilité aux soins de santé, tout en soutenant actuellement plus de 2,5 millions de patients à travers plus de 100 marques uniques pour plus de 25 indications thérapeutiques.

À propos d’Arsenal Capital Partners

Arsenal Capital Partners est une société de capital d’investissement privée de premier plan qui se spécialise dans la création d’entreprises industrielles de croissance et de soins de santé leaders sur le marché. Depuis sa création en 2000, Arsenal a levé des fonds d’investissement institutionnels d’un montant total de plus de 10 milliards de dollars, réalisé plus de 300 acquisitions de plateformes et d’actifs complémentaires, et plus de 35 cessions. La société travaille avec des équipes de gestion pour créer des entreprises d’importance stratégique avec des positions de leader sur le marché, une croissance élevée et une forte valeur ajoutée. Pour plus d’informations, rendez–vous sur www.arsenalcapital.com.

À propos de Fortrea

Fortrea (Nasdaq : FTRE) est l’un des principaux fournisseurs mondiaux de solutions de développement clinique dans le secteur des sciences de la vie. Fortrea s’associe à des sociétés établies et émergentes du domaine biopharmaceutique, de la biotechnologie des dispositifs médicaux et des diagnostics pour stimuler l’innovation en matière de santé, et accélérer la mise au point de traitements révolutionnaires pour les patients. Fortrea propose des services de gestion d’essais cliniques de phase I à IV, de pharmacologie clinique et de consulting. Nos solutions s’appuient sur 30 ans d’expérience dans 20 domaines thérapeutiques, une passion pour la rigueur scientifique, des connaissances exceptionnelles et un solide réseau de centres de recherche. Notre équipe talentueuse et diversifiée répartie dans plus de 90 pays est dimensionnée pour fournir des solutions ciblées et agiles à nos clients, partout dans le monde. Pour en savoir plus sur la manière dont Fortrea est un moteur d’influence du pipeline au patient, rendez–vous sur Fortrea.com et suivez–nous sur LinkedIn et X (anciennement Twitter).

Mise en garde concernant les déclarations prospectives

Le présent communiqué de presse contient des « déclarations prospectives » au sens des lois fédérales sur les valeurs mobilières, notamment la Section 27A du Securities Act (la loi américaine sur les valeurs mobilières) et la Section 21E de l’Exchange Act (la loi américaine sur les Bourses de valeurs). Les déclarations prospectives traitent par nature de questions qui sont, à des degrés divers, incertaines, y compris le moment de l’utilisation du produit net pour rembourser une partie de l’encours de la dette de la Société. Dans ce contexte, les déclarations prospectives traitent souvent des performances commerciales et financières futures attendues et de la situation financière, et contiennent fréquemment des termes tels que « orientation », « s’attendre à », « supposer », « anticiper », « avoir l’intention », « planifier », « prévoir », « croire », « viser », « sera », « serait », « cible », des expressions similaires, ainsi que des variantes ou la forme négative de ces termes qui sont destinés à identifier les déclarations prospectives, bien que toutes les déclarations prospectives ne contiennent pas ces mots d’identification. Les résultats réels pourraient sensiblement différer de ces déclarations prospectives en raison d’un certain nombre de facteurs, y compris, mais sans s’y limiter, les facteurs décrits en tant que de besoin dans les documents que la Société dépose auprès de la Securities and Exchange Commission (« SEC »). Pour une analyse plus approfondie des risques liés à l’activité de la Société, voir la section « Facteurs de risque » du Rapport annuel de la Société sur le Formulaire 10–K, telle qu’elle a été déposée auprès de la SEC, ces facteurs de risque pouvant être modifiés ou mis à jour en tant que de besoin dans les dépôts périodiques et autres de la Société introduits auprès de la SEC, qui sont accessibles sur le site Web de la SEC à l’adresse suivante : www.sec.gov. Ces facteurs ne doivent pas être considérés comme exhaustifs et doivent être lus conjointement avec les autres avertissements inclus ou incorporés par référence dans les documents déposés par la Société auprès de la SEC. Toutes les déclarations prospectives sont faites uniquement à la date du présent communiqué et la Société ne s’engage pas, sauf si la loi l’exige, à mettre à jour ou à réviser les déclarations prospectives pour tenir compte d’événements ou de développements futurs.

Coordonnées de Fortrea :
Hima Inguva (Investisseurs) – 877–495–0816, hima.inguva@fortrea.com
Sue Zaranek (Médias) – 919–943–5422, media@fortrea.com
Kate Dillon (Médias) – 646–818–9115, kdillon@prosek.com

Contact Arsenal :

Ellen Pavlovsky – epavlovsky@arsenalcapital.com


GLOBENEWSWIRE (Distribution ID 9148950)

IdentiFlight présente sa technologie V5 ciblée sur une meilleure protection de la faune dans les parcs éoliens

LOUISVILLE, État du Colorado, 05 juin 2024 (GLOBE NEWSWIRE) — IdentiFlight, un acteur leader des systèmes anticollision aviaire conçus pour les parcs éoliens, est fière d’annoncer le lancement de sa technologie V5, qui constitue une avancée majeure en termes de performances et de fiabilité. En s’appuyant sur l’expérience éprouvée de la Société en matière de protection des espèces d’oiseaux et en s’inscrivant dans une démarche d’accompagnement du développement des énergies renouvelables, la V5 d’IdentiFlight établit une nouvelle norme en matière d’efficacité des systèmes de détection aviaire.

« Nous sommes ravis de dévoiler notre technologie V5, qui marque une avancée de taille dans la protection des espèces présentes dans les parcs éoliens », observe Carlos Jorquera, PDG et directeur technique de Boulder Imaging, la société responsable du développement d’IdentiFlight, avant d’ajouter : « Cette étape reflète notre engagement inébranlable en faveur d’un avenir durable, où l’énergie propre se développe positivement au cœur d’écosystèmes prospères. »

Principales caractéristiques de la solution :

Meilleure performance : la V5 gagne en précision et en efficacité de détection, permettant la rapide et fiable identification et classification des espèces d’oiseaux, notamment ceux faisant partie de la famille des rapaces comme les aigles, les faucons ou les éperviers, et prolonge le périmètre de détection jusqu’à 1,3 km.

Robuste conception : grâce à ses solides armoires de commande capables de résister à des conditions environnementales difficiles, la V5 est optimisée pour être exploitable dans divers territoires, y compris, désormais, les zones côtières.

Meilleur entretien : le nouveau design de la V5 facilite sa maintenance et son entretien, minimisant ainsi les temps d’arrêt et optimisant l’efficacité opérationnelle pour les exploitants de parcs.

Le premier déploiement de la V5 aura lieu dans le parc éolien de Musselroe en Tasmanie, et se fera en collaboration avec Woolnorth Renewables. « L’installation de la V5 d’IdentiFlight à Musselroe souligne notre engagement à protéger les espèces emblématiques de Tasmanie que sont le pygargue à queue cendrée et l’aigle pêcheur à poitrine blanche », remarque Jie Yao, directeur général de Woolnorth Renewables. Et de conclure : « Nous reconnaissons que les solutions de pointe, telles qu’IdentiFlight, jouent un rôle clé dans l’atténuation des risques potentiels des parcs éoliens, à l'heure où que nous faisons progresser les initiatives essentielles en matière d’énergie propre en Tasmanie et en Australie. »

Don Mills, président et directeur de l’exploitation de Boulder Imaging, ajoute : « Avec Woolnorth Renewables, nous sommes fiers d’écrire un nouveau chapitre en matière de protection des espèces. Déployer la technologie V5 d’IdentiFlight dans le parc éolien de Musselroe va au–delà du concept d’innovation pour établir un nouveau référentiel en protection de la faune dans les parcs éoliens. Ce partenariat représente bien plus qu’une simple collaboration ; il traduit un engagement commun en faveur de la préservation et du progrès. »

Pour plus d’informations sur la façon dont IdentiFlight et sa technologie V5 contribuent à la protection des espèces, tout en optimisant la production d’énergie à l’appui de résultats probants, veuillez consulter le site IdentiFlight.com.

À propos d’IdentiFlight et de son fonctionnement

Mis au point par Boulder Imaging, Inc., IdentiFlight fait appel à une technologie de pointe en matière de visualisation automatique et d’intelligence artificielle pour atteindre un taux de précision de 99 % dans l’identification des espèces aviaires présentes au sein des parcs éoliens dans un rayon de 1,3 km. Des logiciels spécialisés et des réseaux neuronaux analysent rapidement les images, déterminant la position 3D, la vitesse, la trajectoire et les espèces spécifiques.

IdentiFlight protège les oiseaux dans les parcs éoliens opérationnels en réduisant le risque de collision avec les pales des éoliennes et réduit les pertes d’énergie grâce à une réduction éclairée. En outre, le système contribue à la réalisation de projets d’énergie éolienne en mesurant l’activité des oiseaux sur les sites potentiels. Déployé à l’échelle mondiale depuis 2016 et validé de manière indépendante sur plusieurs années, le système IdentiFlight active désormais la protection des oiseaux sur des centaines d’éoliennes à travers le monde. Des recherches indépendantes soulignent l’efficacité de ce système, qui a permis de réduire de plus de 85 % le nombre de décès d’aigles par rapport à d’autres méthodes antérieures d’atténuation.
Pour de plus amples informations, consultez le site Internet d’IdentiFlight.

Un extrait vidéo annexé au présent communiqué est disponible en cliquant sur ce lien.

Une photo accompagnant le présent communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/e2544c63–b7ac–4bc7–a172–f522ab070125

Une photo accompagnant le présent communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/30bff975–5fd7–436a–850b–26fa8f1e6273


GLOBENEWSWIRE (Distribution ID 9148117)

IdentiFlight Debuts V5 Technology: Elevating Wind Farm Wildlife Protection

LOUISVILLE, Colo., June 04, 2024 (GLOBE NEWSWIRE) — IdentiFlight, a leader in avian anti–collision systems for wind farms, is proud to announce the launch of its V5 technology. IdentiFlight V5 represents a significant advancement in both performance and reliability. Building upon IdentiFlight's proven track record of safeguarding avian species while supporting the expansion of renewable energy, IdentiFlight V5 sets a new standard for efficiency and effectiveness in avian detection systems.

“We are thrilled to unveil our V5 technology, representing a significant leap forward in species protection at wind farms,” Carlos Jorquera, CEO and CTO of Boulder Imaging – the company responsible for developing IdentiFlight – remarked. “This milestone reflects our unwavering dedication to a sustainable future, where clean energy flourishes alongside thriving ecosystems.”

Key features of IdentiFlight V5 include:

Enhanced Performance: V5 boasts improved detection accuracy and efficiency, ensuring swift and reliable identification and classification of bird species, particularly raptors such as eagles, hawks, and falcons, expanding detection to a 1.3 km range.

Ruggedized Design: With ruggedized control cabinets capable of withstanding harsh environmental conditions, V5 is optimized for deployment in diverse landscapes, now including coastal areas.

Streamlined Serviceability: The new design of V5 facilitates easier maintenance and serviceability, minimizing downtime and optimizing operational efficiency for wind farm operators.

The debut deployment of V5 will take place at the Musselroe Wind Farm in Tasmania, in collaboration with Woolnorth Renewables. “The installation of IdentiFlight V5 at Musselroe underscores our dedication to protecting Tasmania's iconic wedge–tailed eagle and white–bellied sea eagle,” Jie Yao, Woolnorth Renewables General Manager, stated. “We recognize that cutting–edge solutions, such as IdentiFlight, are integral to mitigating potential risks of wind farms as we advance critical clean energy initiatives across Tasmania and Australia.”

Boulder Imaging President and COO, Don Mills went on to say, “Together with Woolnorth Renewables, we're proud to pioneer this next chapter in species protection. By deploying IdentiFlight's V5 technology at the Musselroe Wind Farm, we're not just innovating; we're setting new benchmarks for wildlife protection in wind farms. This partnership represents more than just a collaboration; it's a shared commitment to conservation and progress.”

For more information on how IdentiFlight and their V5 technology offers species protection, while maximizing power generation with proven results, please visit IdentiFlight.com.

About IdentiFlight and How it Works

Developed by Boulder Imaging, Inc., IdentiFlight utilizes cutting–edge machine vision and AI technology to achieve a 99% accuracy rate in identifying avian species within a 1.3 km range in wind farms. Specialized software and neural networks swiftly analyze images, determining 3D position, speed, trajectory, and specific species.

IdentiFlight safeguards birds in operational wind farms by reducing collision risk with turbine blades and reduces energy loss through informed curtailment. Additionally, it supports wind energy projects by quantifying bird activity at potential sites. Deployed globally since 2016 and independently validated over multiple years, the IdentiFlight system now protects for hundreds of wind turbines worldwide. Independent research underscores its effectiveness, showcasing over 85% reduction in eagle fatalities over previous mitigation methods.

Explore further at IdentiFlight's website.

IDENTIFLIGHT DEBUTS V5 TECHNOLOGY

A Media Snippet accompanying this announcement is available by clicking on this link.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e2544c63–b7ac–4bc7–a172–f522ab070125

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/30bff975–5fd7–436a–850b–26fa8f1e6273


GLOBENEWSWIRE (Distribution ID 9146975)

IdentiFlight stellt V5-Technologie vor: Verbesserter Schutz von Wildtieren in Windparks

LOUISVILLE, Colorado, June 05, 2024 (GLOBE NEWSWIRE) — IdentiFlight, ein führender Anbieter von Antikollisionssystemen für Windparks, ist stolz darauf, die Einführung seiner V5–Technologie bekannt zu geben. IdentiFlight V5 stellt einen bedeutenden Fortschritt in Bezug auf Leistung und Zuverlässigkeit dar. Aufbauend auf der bewährten Erfolgsgeschichte von IdentiFlight beim Schutz von Vogelarten und der gleichzeitigen Förderung des Ausbaus erneuerbarer Energien setzt IdentiFlight V5 einen neuen Standard für Effizienz und Effektivität von Vogelerkennungssystemen.

„Wir freuen uns, unsere V5–Technologie vorzustellen, die einen bedeutenden Fortschritt für den Artenschutz in Windparks darstellt“, so Carlos Jorquera, CEO und CTO von Boulder Imaging, dem Unternehmen, das IdentiFlight entwickelt. „Dieser Meilenstein spiegelt unser unermüdliches Engagement für eine nachhaltige Zukunft wider, in der saubere Energie neben florierenden Ökosystemen gedeiht.“

Zu den wichtigsten Funktionen von IdentiFlight V5 gehören:

Verbesserte Leistung: V5 zeichnet sich durch eine verbesserte Erkennungsgenauigkeit und –effizienz aus, die eine schnelle und zuverlässige Identifizierung und Klassifizierung von Vogelarten, insbesondere von Greifvögeln wie Adlern, Habichten und Falken, gewährleistet und die Erkennung auf eine Reichweite von 1,3 km erweitert.

Widerstandsfähiges Design: Mit robusten Schaltschränken, die auch rauen Umgebungsbedingungen standhalten, ist V5 für den Einsatz in verschiedenen Landschaften, jetzt auch in Küstenregionen, optimiert.

Optimierte Wartungsfreundlichkeit: Das neue Design von V5 erleichtert die Wartung und Instandhaltung, minimiert Ausfallzeiten und optimiert die Betriebseffizienz für Windparkbetreiber.

Der erste Einsatz von V5 wird im Windpark Musselroe in Tasmanien in Zusammenarbeit mit Woolnorth Renewables erfolgen. „Die Installation von IdentiFlight V5 in Musselroe unterstreicht unser Engagement für den Schutz des symbolträchtigen tasmanischen Keilschwanzadlers und des Weißbauch–Seeadlers“, so Jie Yao, General Manager von Woolnorth Renewables. „Wir sind uns bewusst, dass innovative Lösungen wie IdentiFlight wesentlich dazu beitragen, die potenziellen Risiken von Windparks zu mindern, während wir wichtige Initiativen für saubere Energie in Tasmanien und Australien vorantreiben.“

Don Mills, President und COO von Boulder Imaging, dazu weiter: „Wir sind stolz darauf, gemeinsam mit Woolnorth Renewables dieses nächste Kapitel des Artenschutzes aufzuschlagen. Mit dem Einsatz der V5–Technologie von IdentiFlight im Windpark Musselroe sind wir nicht nur innovativ, sondern setzen neue Maßstäbe für den Schutz von Wildtieren in Windparks. Diese Partnerschaft ist mehr als nur eine Zusammenarbeit, sie ist ein gemeinsames Engagement für Umweltschutz und Fortschritt.“

Weitere Informationen darüber, wie IdentiFlight und seine V5–Technologie zum Artenschutz beitragen und gleichzeitig die Energieerzeugung mit bewährten Ergebnissen maximieren, finden Sie unter IdentiFlight.com.

Über IdentiFlight und wie es funktioniert

Das von Boulder Imaging, Inc. entwickelte IdentiFlight nutzt modernste Bildverarbeitungs– und KI–Technologien, um eine 99–prozentige Genauigkeit bei der Identifizierung von Vogelarten innerhalb eines Bereichs von 1,3 km in Windparks zu erreichen. Spezialisierte Software und neuronale Netze analysieren Bilder schnell und bestimmen 3D–Position, Geschwindigkeit, Flugbahn und spezifische Arten.

IdentiFlight schützt Vögel in Windparks, indem es das Risiko von Kollisionen mit den Turbinenblättern verringert und Energieverluste durch gezielte Drosselung reduziert. Darüber hinaus unterstützt es Windenergieprojekte durch die Quantifizierung der Vogelaktivität an potenziellen Standorten. Das seit 2016 weltweit eingesetzte und über mehrere Jahre hinweg unabhängig validierte IdentiFlight–System schützt mittlerweile Hunderte von Windkraftanlagen weltweit. Unabhängige Forschungen belegen die Wirksamkeit des Systems: Die Zahl der getöteten Adler ist im Vergleich zu früheren Methoden um über 85 % gesunken.
Weitere Informationen finden Sie auf der Website von IdentiFlight.

Ein Medien–Snippet zu dieser Mitteilung ist verfügbar, indem Sie auf diesen Link klicken

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/e2544c63–b7ac–4bc7–a172–f522ab070125

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/30bff975–5fd7–436a–850b–26fa8f1e6273


GLOBENEWSWIRE (Distribution ID 9148117)

Tealium’s Digital Velocity conferences return globally

San Diego, June 04, 2024 (GLOBE NEWSWIRE) —  Tealium, the largest independent and most trusted customer data platform (CDP), is hosting three flagship Digital Velocity conferences in–person for customers and partners in North America, Europe, and Asia Pacific regions. This year's theme, Welcome to the Real–Time Revolution: Where Moments Matter, will showcase how customer data can be used to enhance business and customer experience results, specifically in the areas of AI, privacy, and compliance.

“The experience economy is undergoing major shifts driven by the acceleration of AI and evolving global privacy regulations,” said Jeff Lunsford, CEO of Tealium. “Tealium’s real–time platform helps brands take customer experience initiatives to new heights. We enable companies to dazzle customers during their most pivotal moments through data–driven personalization and seamless digital experiences that prioritize trust and respect for consumer privacy. This year at Digital Velocity, we will be deep–diving into how we make that possible for the enterprises we serve globally, featuring use cases directly from our customers.” 

Below are the schedules for Tealium’s 2024 Digital Velocity conferences:

This year, Tealium announces strategic investments in several areas as part of its commitment to innovation:

  • The Tealium Trust Platform: Tealium’s standardized and governed infrastructure for real–time data applications and increased observability to orchestrate compliant customer data flows. This is a culmination of advancements to Tealium’s user interface (UI), embedded analytics, integration marketplace, and more. 
  • Real–Time Data: The Tealium Moments API and Tealium Moments IQ are just the start of the company’s zero– and first–party real–time data solutions. These features provide real–time insights in new and more flexible ways to own the moments that matter most. 
  • Artificial Intelligence: Data readiness is the foundation for AI success. Tealium is investing heavily in existing and new AI–powered solutions for more intelligent insights. 
    • Tealium Predict: DIY–style, machine learning technology for enhanced customer experience initiatives.  
    • Tealium Genius: New AI assistant to boost productivity and support teams in better understanding their data layer.
    • Tealium for AI: Fuel AI models with consented, filtered, and enriched data in real–time.
  • Expanded Partnerships: Embrace stack composability to leverage customers’ existing and new partner integrations for a more centralized infrastructure.
    • Tealium’s Cloud Data Warehouse Partner Ecosystem: A collection of integrations to work in harmony with cloud data providers, like Snowflake.
    • Global Ad Partner Expansion: New integration capabilities to accelerate ad performance and measurement with Snap, Pinterest, LinkedIn, The Trade Desk, Reddit, and more. 

Tealium is also continuing to innovate within highly–regulated industries and has now launched Tealium for Healthcare. This new suite of solutions supports healthcare companies in reimagining the patient experience, all while prioritizing HIPAA compliance. The solution includes the following features: consent management, identity resolution for unified customer views, and secure data routing to protect PHI across the entire customer journey, among others. 

To learn more and register for a Digital Velocity event in your region, visit tealium.com/events.

To keep up with the latest company news, visit Tealium’s Newsroom.

About Tealium
As the most trusted CDP, Tealium connects data so businesses can better connect with their customers. Tealium’s real–time data infrastructure allows brands to power their AI models and activate data for enhanced in–the–moment experiences. Tealium’s turnkey integration ecosystem supports more than 1,300 built–in connections from the world’s most prominent technology experts. Tealium's solutions include a real–time customer data platform with machine learning, tag management, an API hub, and data management solutions that make customer data more valuable, actionable, privacy–compliant, and secure. Named as a Leader in the Gartner® Magic Quadrant for Customer Data Platforms™, more than 850 leading businesses globally trust Tealium to power their customer data strategies. For more information, visit www.tealium.com


GLOBENEWSWIRE (Distribution ID 9148412)

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market–leading, technology–rich healthcare and industrial growth companies.

Endpoint and FPA provide best–in–class Randomization and Trial Supply Management (RTSM) and patient access solutions respectively. They both represent strategically differentiated entry points within the pharmaceutical services value chain, where Arsenal holds significant domain, scientific and technical knowledge.

Arsenal has appointed Sam Osman, former president of Fortrea’s Enabling Services segment, to serve as chief executive officer of the new entities, and Raymond (“Ray”) H. Hill, an operating partner within Arsenal’s healthcare team, will serve as chairman of the board.

“Endpoint and FPA are distinctly positioned to support the patient journey across clinical trials and through access to novel therapeutics after approval,” said Sam Osman, chief executive officer of Endpoint and FPA. “With Arsenal as our partner, I am confident that both our businesses and our teams will benefit from accelerated growth opportunities as well as investment and executive focus, resulting in enhanced capabilities and solutions for customers.”

“The successful closing of this transaction is a testament to the caliber of the teams involved, who have planned a smooth transition for colleagues, customers and the patients we serve,” said Fortrea Chairman and CEO Tom Pike. “This transaction enables both organizations to focus their leadership and resources on delivering optimal solutions for our customers. As previously disclosed, the net proceeds from this divestiture will be used to reduce a portion of Fortrea’s overall debt structure. As a pure–play clinical CRO, Fortrea remains committed to our mission of delivering solutions that bring life–changing treatments to patients faster.”

Ray Hill, an operating partner of Arsenal and chairman of the board for Endpoint and FPA, said, “I am incredibly excited to be a part of Endpoint and FPA’s next chapter. I look forward to working with the management team in building a strategically important company that provides data–driven solutions for patients.”

Endpoint Clinical
Endpoint operates in the high growth eClinical market as a leading provider of Randomization and Trial Supply Management (RTSM) solutions to biopharmaceutical and CRO customers with expertise in serving complex and late–stage clinical trials. For more than 15 years, Endpoint has had a successful track record of effectively supporting more than 1,750 clinical trials involving 875,000 patients across 90 countries and has cultivated a blue–chip customer base and nurtured long–standing strategic relationships.

Fortrea Patient Access
Fortrea Patient Access is a scaled leader in the HUB services and patient access market, serving the biopharmaceutical industry with comprehensive patient support, product access, affordability and adherence solutions for more than 30 years. Further advanced by its recently expanded non–commercial specialty pharmacy, FortreaRx™, to support enhanced distribution of cold–chain and ambient free goods products, Fortrea Patient Access is committed to driving patient outcomes and improving healthcare accessibility through its extensive experience while currently supporting more than 2.5 million patients and over 100 unique brands across more than 25 disease indications.

About Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity investment firm that specializes in building market–leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 300 platform and add–on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth and high value–add.  For more information, visit www.arsenalcapital.com.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I–IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Cautionary Statement Regarding Forward–Looking Statements

This press release contains “forward–looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward–looking statements by their nature address matters that are, to different degrees, uncertain, including the timing of the use of net proceeds to repay a portion of the Company’s outstanding debt. In this context, forward–looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward–looking statements, although not all forward–looking statements contain these identifying words. Actual results could differ materially from these forward–looking statements due to a number of factors, including, but not limited to factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company’s business, see the “Risk Factors” Section of the Company’s Annual Report on Form 10–K, as filed with the Securities and Exchange Commission (the “SEC”), as such risk factors may be amended or updated from time to time in the Company’s subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in the Company’s filings with the SEC. All forward–looking statements are made only as of the date of this release, and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward–looking statements to reflect future events or developments.

Fortrea Contacts:
Hima Inguva (Investors) – 877–495–0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919–943–5422, media@fortrea.com
Kate Dillon (Media) – 646–818–9115, kdillon@prosek.com

Arsenal Contact:

Ellen Pavlovsky – epavlovsky@arsenalcapital.com           


GLOBENEWSWIRE (Distribution ID 9147983)

Dr. Pumla Gobodo-Madikizela Receives 2024 Templeton Prize

West Conshohocken, Pennsylvania, USA, June 04, 2024 (GLOBE NEWSWIRE) — The winner of the 2024 Templeton Prize is Dr. Pumla Gobodo–Madikizela. Dr. Gobodo–Madikizela is a professor and South African National Research Foundation’s Chair in Violent Histories and Transgenerational Trauma and the Director of the Centre for the Study of the Afterlife of Violence and the Reparative Quest at Stellenbosch University. Her insights into the mechanisms of trauma and forgiveness in post–apartheid South Africa have created a globally recognized model for social healing in the aftermath of conflict, a model she calls “the reparative quest.”

“The 2024 Templeton Prize winner, Dr. Pumla Gobodo–Madikizela, has a remarkable grasp of the personal and social dynamics that allow for healing in societies wounded by violence,” said Heather Templeton Dill, President of the John Templeton Foundation. “As a psychologist, scholar, and commentator, she has served as a guiding light within South Africa as it charts a course beyond apartheid, facilitating dialogue to help people overcome individual and collective trauma. Her work underscores the importance in contemporary life of cultivating the spiritual values of hope, compassion, and reconciliation.”

Gobodo–Madikizela, 69, was an influential member of the Human Rights Violations Committee of South Africa’s Truth and Reconciliation Commission that aimed to address the injustices of apartheid. Her award–winning 2003 book A Human Being Died That Night recounts her conversations with the former commander of state–sanctioned death squads, Eugene de Kock, and argues for the possibility of remorse, accountability, and forgiveness. 

Her career as a scholar and a public figure is distinguished by her effort to repair ruptures created by past violence and to build a path toward healing and restoration in an ongoing process she calls “the reparative quest.” In international lectures and books, she displays keen powers of sympathy and a deep feeling of humanity toward victims as well as perpetrators of traumatic experiences. 

Dill added: “Her achievements mark her as a leading figure in understanding and confronting the deeply rooted psychological scars borne by those who experienced unimaginable loss.” 

In a statement for the Templeton Prize, Gobodo–Madikizela said: “Through the many encounters I had in my work when I served on the Truth and Reconciliation Commission, I learned that ordinary people, under certain circumstances, are capable of far greater evil than we could have imagined. But so are we capable of far greater virtue than we might have thought. My research is based on this possibility of human transformation, on probing deeper to understand the conditions necessary to restore the values of what it means to be human—to want to preserve the dignity and life of the other. This is the essence of an accountable Ubuntu, a word from my language that is a foundational moral force that reaffirms our shared humanity. I feel a deep sense of gratitude for this prize. The great opportunity it opens for me to work with the next generation of future leaders who will pursue research on these urgent questions is a rare gift.”

Background

Gobodo–Madikizela was born in 1955 in Langa, one of the oldest townships designated for Black residents outside Cape Town, South Africa. She is the eldest daughter of Tukela and Nobantu Gobodo. Growing up under apartheid, she bore witness to the harm of segregation, discrimination, racism, and state brutality. She remembered hiding as tanks drove through her neighborhood. Only when returning to the area in freedom later in life could she appreciate the natural beauty of her home: until the end of apartheid, “I never actually thought of Cape Town as my city,” she said in a video statement for the Templeton Prize, adding that now many South Africans once excluded from society can appreciate the country’s beauty as an “act of reclamation.” Amid this outer oppression and strife, her loving parents raised her with compassion and instilled in her the values of integrity and caring for others.

She went to a boarding high school at Inanda Seminary in Durban, at the time the only private school for Black girls in South Africa, then pursued a bachelor’s degree in psychology at the University of Fort Hare. She later earned a master’s degree in clinical psychology from Rhodes University, focusing on the effects of apartheid on the psychological well–being of Black South Africans. Her early research laid the foundation for her lifelong commitment to exploring the emotional and psychological toll of apartheid on both victims and perpetrators, an interest that led to her doctoral research on violence. She graduated with a PhD degree in psychology from the University of Cape Town.

In the 1990s, with the end of apartheid, Gobodo–Madikizela joined the Truth and Reconciliation Commission (TRC) and served as the Chair of the Human Rights Violations Committee in the Western Cape office of the TRC, based in Cape Town. In this role, she served alongside 2013 Templeton Prize winner Archbishop Desmond Tutu, who was appointed by Nelson Mandela to chair the TRC. Her interactions with apartheid–era perpetrators, including Eugene de Kock, a former police colonel who was nicknamed “Prime Evil,” led her to grapple with the profound question of whether forgiveness could be extended to those who had committed heinous crimes.

Her groundbreaking multiple award–winning book A Human Being Died That Night: A South African Story of Forgiveness, recently reprinted as a Mariner Classic, was a result of her interviews with Eugene de Kock. In the book, she explores the inner workings of forgiveness and the capacity of human beings to empathize with one another, even in the darkest of circumstances. The book has been published in multiple translations and was winner of the Alan Paton Award (known as the “Pulitzer” for South African non–fiction), and the Christopher Award. The book was adapted into a stage play that premiered at the Hampstead Theatre in London in 2013.

Gobodo–Madikizela’s academic career continued to flourish, and she held various prestigious positions at institutions such as the University of Cape Town, University of the Free State, and Stellenbosch University. Her research explored topics including empathy, and forgiveness, post–apartheid identity, post–Holocaust dialogue, transgenerational trauma, and memory. She has authored articles and edited and co–edited book volumes on these topics. Gobodo–Madikizela is a socially engaged scholar and has remained focused on research on the transgenerational legacies of historical trauma and the “reparative quest” that must follow to restore justice in society. 

In addition to A Human Being Died That Night, she is the co–author of Narrating Our Healing: Perspectives on Healing Trauma (2007). She has edited and co–edited several book volumes including Memory, Narrative and Forgiveness: Perspectives on the Unfinished Journeys of the Past (2009), as co–editor, as editor of Breaking Intergenerational Cycles of Repetition: A Global Dialogue on Historical Trauma and Memory (2019), and History, Trauma and Shame: Engaging the Past through Second Generation Dialogue (2020), and co–editor of the anthology Post–Conflict Hauntings: Transforming Collective Memories of Historical Trauma (2020).

Gobodo–Madikizela is a Radcliffe Institute fellow. Among the honors she has received are: The Harry Oppenheimer Fellowship Award (2020), considered the most prestigious academic award in Africa, an honorary Doctor of Laws from Rhodes University (2019); honorary Doctor of Theology from the Friedrich–Schiller University, Germany (2017), and she received the “Social Change Award” from Rhodes University for “a contribution made by a leading psychologist to social change in South Africa.” Since 2017 she has held an honorary professorial position at Queen’s University, Belfast, affiliated with the Senator George J. Mitchell Institute for Global Peace, Security and Justice. 

Dr. Gobodo–Madikizela joins a list of 53 Prize recipients including St. Teresa of Kolkata (the inaugural award in 1973) and the Dalai Lama (2012). The 2023 Templeton Prize was awarded to the nurse and midwife, Dr. Edna Adan Ismail. Preceding her was theoretical physicist Dr. Frank Wilczek (2022) and ethologist and conservationist Dr. Jane Goodall (2021). Other social scientists who have won the Prize include Michael Bourdeaux, founder of the Keston Institute, and Michael Novak, philosopher and diplomat. She is the third South African to win the award, preceded by Archbishop Desmond Tutu (2013) and physicist George Ellis (2004).

###

 Notes to Editors 

About the Templeton Prize
Established in 1972, the Templeton Prize is one of the world’s largest annual individual awards. It is given to honor individuals whose exemplary achievements advance Sir John Templeton’s philanthropic vision: harnessing the power of the sciences to explore the deepest questions of the universe and humankind’s place and purpose within it. Currently valued at £1.1 million GBP, the award is adjusted periodically so it always exceeds the value of the Nobel Prize. Winners have come from a wide range of faiths, fields, and geographies, and have included Nobel Prize winners, philosophers, theoretical physicists, and one canonized saint. The Templeton Prize is awarded by the three Templeton philanthropies: the John Templeton Foundation, based in West Conshohocken, Pennsylvania, and by the Templeton World Charity Foundation and Templeton Religion Trust, based in Nassau, The Bahamas. To learn more, visit TempletonPrize.org

Contact:
Benjamin Carlson 
bcarlson@templeton.org 

Thomas Burnett
tburnett@templeton.org 

Attachments


GLOBENEWSWIRE (Distribution ID 9147796)

Explainer: How India’s Political Parties Neglect Climate Change

A Kashmiri farmer smokes a traditional hookah on his farmland during a break from paddy cultivation. High temperatures are impacting farms across India. Credit: Umar Manzoor Shah/IPS

A Kashmiri farmer smokes a traditional hookah on his farmland during a break from paddy cultivation. High temperatures are impacting farms across India. Credit: Umar Manzoor Shah/IPS

By Umar Manzoor Shah
NEW DELHI, Jun 4 2024 – As India’s 968.8 million voters were gripped by election fever, the worst-ever heat wave held the country in its clutches. 

The Indian capital, New Delhi, recorded the country’s highest ever temperature of 52.9 degrees Celsius (127.22 °F) on May 28. More than 50 people died within a week due to heat stroke across the country. However, ironically, despite climate change and the havoc it is unleashing upon the country’s inhabitants, there was scant mention of it in the manifestos of the 744 political parties contesting the elections. 

India and the Heat Wave

The year 2022 was called the hottest summer ever. That year, it was so hot in India that it broke the 122-year-old record. But then came 2023, when the summer season was so scorching hot that scientists said it was the hottest summer in the last 2,000 years in the northern hemisphere. But then came the year 2024. From January to June, all months were recorded as the hottest months ever. In the Indian state of Uttarakhand, there were forest fires. In the first week of May, forest fires were seen in states like Odisha, Chhattisgarh, Madhya Pradesh, and Jharkhand. Heat wave warnings are being issued all over the country, even in places like the southern Indian state of Kerala, where, until recently, heat waves were seldom recorded.

The pervasive heat waves are putting the country’s poor in dire straits. Roadside laborers are dying, and thousands of acres of crops are withering in the heat, affecting millions of people in India’s agriculture sector.

What is a heat wave?

The Indian Meteorological Department will announce a heat wave warning if the temperature on the plains is above 40°C, above 37°C in the coastal areas, and above 30°C in the mountains, or if, for two consecutive days, the temperature is 4.5°C above normal. And if it is 6.4°C above normal for two consecutive days, it is considered a severe heat wave. And if the temperature exceeds 45°C without checking any other conditions, a heat wave is declared.

But, in many cases, the Indian Meteorological Department issues a heat index warning rather than just talking about the temperature. 

What is a heat index? 

Humidity impacts how heat is experienced. So if two places have a temperature of 45°C, but one is more humid, it feels hotter. This is because the moisture in the air means that sweat on the skin doesn’t evaporate as easily. 

In places like the southern Indian city of Chennai, humidity is much higher compared to Delhi. So people feel hotter in Chennai due to the humidity, even when the temperature is lower.  To measure this, there is a heat index that indicates how hot it feels, rather than just measuring temperature. These extreme temperatures are killing people because its difficult to cool their bodies down. 

‘We will all go insane before dying’

According to a report from March 2023, non-communicable diseases were responsible for 1 out of every 4 deaths in India, all because of the heat. In Delhi alone, heat was responsible for 11 percent of deaths.

Prashant Tripathi, known as Acharya Prashant, an Indian philosopher and author, says the situation in India has reached a point where there is a threat of mass insanity looming in the country. Prashant claims that poor people will be the most severely impacted by climate change and that before they pass away, they will go insane, wander around in dry clothes, and attack one another. “This is a very serious matter. You see, when a person is suffering from a high fever, he blabs nonsensical things. The same could be the situation for heat waves. You will see an epidemic of mass insanity happening in the country. We will first go insane and then die—one by one,” he said.

According to him, the political parties have become so consumed with the race to win power that they do not even give a damn about these crucial issues.

Climate change and India’s electoral landscape

While going through the poll manifestos of India’s major political parties, climate change finds the minutest mention. While the ruling Bharatiya Janata Party (BJP) highlights the importance of fossil fuel reduction for electricity generation, it pledges to work towards achieving net-zero emissions by 2070. The main opposition party, Indian National Congress, claims in its manifesto that it will address the issues of environment and climate change with the seriousness they deserve. The Communist Party of India pledged the promotion of renewable energy, such as solar and wind, if voted to power. Other than this, climate change finds no mention in the massive public rallies that were held across the country during the poll campaign.

Amir Kareem, a research scholar of political science from the University of Kashmir, told IPS that society is so taken up with communal controversies, as issues such as religious diversity and ethnicity are termed in India, that there is little time to look at the real big issue—climate change.

“The Indian political system is still reeling under the crises of providing good roads, free electricity, and jobs. Climate change is not a priority. The main reason is a lack of education and awareness. We are not making our people aware that it is the land, the soil, and the air that are providing us everything. There is crazy stuff of communal hatred, allegations, and counter-allegations, dominating the scene,” Kareem said.

Meanwhile, the million-dollar question remains: Why is the Indian political system playing a proverbial ostrich about the climate change the country is already engulfed in? Only time will tell what price the country will pay for such neglect. As the results pour in, will voters regret not asking heated questions about the climate?

This feature is published with the support of Open Society Foundations.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);